SEC 13F Intelligence

Handelsbanken Fonder AB / GILD

Handelsbanken Fonder AB’s Gilead Sciences Inc Position

Does Handelsbanken Fonder AB own Gilead Sciences Inc (GILD)? Yes1.05M shares worth $147M (+0.49% of its 13F portfolio) as of Q1 2026, down from 1.07M shares the prior filed quarter.

Position Value
$147M
Q1 2026
Shares
1.05M
% of Portfolio
+0.49%
Quarters Held
26
currently held

Position History GILD

Reported value by quarter
Q1 ’19: $11MQ1 ’19Q2 ’19: $7MQ2 ’20: $44MQ3 ’20: $19MQ4 ’20: $21MQ4 ’20Q1 ’21: $20MQ2 ’21: $22MQ3 ’21: $23MQ4 ’21: $23MQ4 ’21Q1 ’22: $20MQ2 ’22: $26MQ3 ’22: $30MQ4 ’22: $54MQ4 ’22Q1 ’23: $54MQ2 ’23: $44MQ3 ’23: $42MQ4 ’23: $46MQ4 ’23Q1 ’24: $37MQ2 ’24: $38MQ3 ’24: $45MQ4 ’24: $55MQ4 ’24Q1 ’25: $123MQ2 ’25: $129MQ3 ’25: $128MQ4 ’25: $131MQ4 ’25Q1 ’26: $147Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.05M$147M+0.49%
Q4 20251.07M$131M+0.40%
Q3 20251.15M$128M+0.41%
Q2 20251.16M$129M+0.46%
Q1 20251.09M$123M+0.51%
Q4 2024590.2K$55M+0.21%
Q3 2024538.7K$45M+0.18%
Q2 2024549.4K$38M+0.16%
Q1 2024499.0K$37M+0.16%
Q4 2023572.2K$46M+0.23%
Q3 2023561.8K$42M+0.24%
Q2 2023576.1K$44M+0.24%
Q1 2023651.1K$54M+0.31%
Q4 2022633.9K$54M+0.34%
Q3 2022488.0K$30M+0.20%
Q2 2022427.5K$26M+0.17%
Q1 2022329.5K$20M+0.11%
Q4 2021312.5K$23M+0.11%
Q3 2021323.8K$23M+0.12%
Q2 2021323.4K$22M+0.12%
Q1 2021309.5K$20M+0.11%
Q4 2020357.1K$21M+0.13%
Q3 2020296.5K$19M+0.14%
Q2 2020577.5K$44M+0.19%
Q2 201999.2K$7M+0.12%
Q1 2019168.7K$11M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of GILD.